Abstract
Purpose
To evaluate the refractive status, anisometropia, amblyopia and strabismus in 3-year-old premature children.
Methods
A total of 161 eyes from 82 premature infants were retrospectively reviewed and divided into three groups according to the presence of retinopathy of prematurity (ROP) and treatment; Group 1 (68 eyes): without ROP, Group 2-1 (32 eyes): spontaneously regressed ROP, and Group 2–2 (61 eyes): regressed ROP with treatment. The incidences and clinical features of refractive errors, anisometropia, amblyopia and strabismus at the age of three years were compared among the three groups.
Results
The incidences of myopia, astigmatism, anisometropia and the severity of myopia increased according to the presence of ROP and treatment (p = 0.03, 0.02, 0.001, and 0.04, respectively). There were no significant differences in the incidences of hyperopia among the three groups; however, the severity of hyperopia in Group 2–2 was higher than those in the other two groups (p = 0.01). Patients in Group 1 had better best corrected visual acuity (BCVA) compared with those of the other two groups (p < 0.001). However, no significant differences in the incidences of strabismus or amblyopia among the three groups (p = 0.80 and 0.85, respectively) were found, and the ratio of esotropia: exotropia was 1:1.3.
References
1. Cooke RW. Preterm mortality and morbidity over 25 years. Arch Dis Child Fetal Neonatal Ed. 2006; 91:F293–4.
2. Cats BP, Tan KE. Premature with and without regressed retinopathy of prematurity: comparison of long-term (6–10years) ophthalmological morbidity. J Pediatr Ophthalmol Strabismus. 1989; 26:271–5.
3. Pennefather PM, Clarke MP, Strong NP, et al. Ocular outcome in children born before 32 weeks gestation. Eye (Lond). 1995; 9(Pt 6 Su):26–30.
4. Robinson R, O'Keefe M. Follow-up study on premature infants with and without retinopathy of prematurity. Br J Ophthalmol. 1993; 77:91–4.
5. Bremer DL, Palmer EA, Fellows RR, et al. Strabismus in premature infants in the first year of life. Arch Ophthalmol. 1998; 116:329–33.
6. Theng JT, Wong TY, Ling Y. Refractive errors and strabismus in premature Asian infants with and without retinopathy of prematurity. Singapore Med J. 2000; 41:393–7.
7. Quinn GE, Dobson V, Repka MX, et al. Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1992; 99:329–40.
8. Page JM, Schneeweiss S, Whyte HE. Ocular sequelae in premature infants. Pediatrics. 1993; 92:787–90.
9. Larsson EK, Rydberg AC, Holmström GE. A population-based study of the refractive outcome in 10-year-old preterm and full-term children. Arch Ophthalmol. 2003; 121:1430–6.
10. Ton Y, Wysenbeek YS, Spierer A, et al. Refractive error in premature infants. J AAPOS. 2004; 8:534–8.
11. Fledelius HC. Preterm delivery and subsequent ocular development. A 7-10 year follow-up of children screened 1982–84 for ROP. 3) refraction. myopia of prematurity. Acta Ophthalmol Scand. 1996; 74:297–300.
12. Holmström G, el Azazi M, Kugelberg U. Ophthalmological long-term follow up of preterm infants: a population based, prospective study of the refraction and its development. Br J Ophthalmol. 1998; 82:1265–71.
13. Quinn GE, Dobson V, Kivlin J, et al. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Ophthalmology. 1998; 105:1292–300.
14. Kwak SI, Kim J-Y, Yu YS. Myopia in premature infants. J Korean Ophthalmol Soc. 1992; 33:1021–7.
15. Lim KH, Yu YS, Chang BL. Clinical features of strabismus in premature baby. J Korean Ophthalmol Soc. 1997; 38:485–90.
16. Lim KH, Yu YS. Myopia vs retinopathy of prematurity. J Korean Ophthalmol Soc. 1998; 39:382–7.
17. Lim KH, Yu YS, Chang BL. Incidence and risk factors of strabismus in premature baby. J Korean Ophthalmol Soc. 1998; 39:1250–4.
18. Cho MS, Park SH, Shin HH. Refractive states of 3–4 years old that underwent cryotherapy in ROP. J Korean Ophthalmol Soc. 2000; 41:483–7.
19. Chung TY, Yu YS. Clinical outcome of spontaneously regressed ROP. J Korean Ophthalmol Soc. 2002; 43:1444–50.
20. Lee HJ, Lim KH. Incidence and factors related to myopia in preterm infant without retinopathy of prematurity. J Korean Ophthalmol Soc. 2002; 43:1950–5.
21. Cho SI, Lim HT, Park SH. The progression of myopia associated with retinopathy of prematurity. J Korean Ophthalmol Soc. 2002; 43:2234–40.
22. Kim J-Y, Kwak SI, Yu YS. Myopia in premature infants at the age of 6 months. Korean J Ophthalmol. 1992; 6:44–9.
23. Choi MY, Park IK, Yu YS. Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness. Br J Ophthalmol. 2000; 84:138–42.
24. The committee for the classification of retinopathy of prematurity: An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984; 102:1130–4.
25. Holmström G, Larsson E. Long-term follow-up of visual functions in prematurely born children-a prospective population-based study up to 10 years of age. J AAPOS. 2008; 12:157–62.
26. O'Connor AR, Stephenson TJ. Change of refractive state and eye size in children of birth weight less than 1701 g. Br J Ophthalmol. 2006; 90:456–60.
27. Holmström GE, Larsson EK. Development of spherical equivalent refraction in prematurely born children during the first 10 years of life: a population-based study. Arch Ophthalmol. 2005; 123:1404–11.
28. O'Connor AR, Wilson CM, Fielder AR. Ophthalmological problems associated with preterm birth. Eye. 2007; 21:1254–60.
29. Ben-Sira I, Nissenkorn I, Weinberger D, et al. Long-term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology. 1986; 93:1423–8.
30. Cho MS, Park SH, Shin HH. Refractive states of 3∼4 years old that underwent cryotherapy in ROP. J Korean Ophthalmol Soc. 2000; 41:483–7.
31. Laws F, Laws D, Clark D. Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study. Br J Ophthalmol. 1997; 81:12–5.
32. Algawi K, Goggin M, O'Keefe M. Refractive outcome following diode laser versus cryotherapy for eyes with retinopathy of prematurity. Br J Ophthalmol. 1994; 78:612–4.
33. McLoone EM, O'Keefe M, McLoone SF, et al. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity. J AAPOS. 2006; 10:454–9.
34. McLoone E, O'Keefe M, McLoone S, et al. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Br J Ophthalmol. 2006; 90:754–9.
35. Yu YS, Kim SM, Kwon J-Y, et al. Preschool vision screening in Korea, preliminary study. J Korean Ophthalmol Soc. 1991; 32:1092–6.
36. Rhee KO, Rhee KI, Rhee KS, et al. Preschool vision screening for amblyopia and refractive errors in Taejon. J Korean Ophthalmol Soc. 1999; 40:1375–84.
37. Kim KI, Ahn SK, Koo BS, et al. Preschool vision screening for 3 to 6-year old children in Seoul. J Korean Ophthalmol Soc. 2002; 43:714–27.
38. Holmström G, Rydberg A. Prevalence and development of strabismus in 10-year-old premature children: a population-based study. J Pediatr Ophthalmol Strabismus. 2006; 43:346–52.
39. O'Connor AR, Stephenson TJ, Johnson A, et al. Strabismus in children of birth weight less than 1701 g. Arch Ophthalmol. 2002; 120:767–73.
40. Pennefather PM, Clarke MP, Strong NP, et al. Risk factors for strabismus in children born before 32 weeks' gestation. Br J Ophthalmol. 1999; 83:514–8.
41. Kvarnström G, Jakobsson P, Lennerstrand G. Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand. 2001; 79:240–4.
43. Chew E, Remaley NA, Tamboli A, et al. Risk factors for esotropia and exotropia. Arch Ophthalmol. 1994; 112:1349–55.
44. Rah SH, Hong SJ, Kim SH. An epidemiologic survey of strabismus among school-children in Korea. J Korean Ophthalmol Soc. 1997; 38:2195–9.
45. Choi KW, Koo BS, Lee HY. Preschool vision screening in Korea: Results in 2003. J Korean Ophthalmol Soc. 2006; 47:112–20.
46. Park HB, Park SH, Shin HH. Analysis of ophthalmic examination for 4 and 5 years old children referred from previous vision screening. J Korean Ophthalmol Soc. 1997; 38:1244–54.
Table 1.
|
Group 1 (N = 34) |
Group 2–1 (N =15) |
Group 2–2 (N =33) |
p value* | ||||
---|---|---|---|---|---|---|---|---|
No | (%) | No | (%) | No | (%) | |||
Gestational age (wk) | <27 | 0 | (0.0) | 1 | (6.7) | 9 | (27.3) | 0.002 |
≥27 | 34 | (100.0) | 14 | (93.3) | 24 | (72.7) | ||
Birth weight (g) | <750 | 0 | (0.0) | 0 | (0.0) | 4 | (12.1) | <0.001 |
750≤ <1000 | 0 | (0.0) | 3 | (20.0) | 7 | (21.2) | ||
1000≤<1500 | 8 | (23.5) | 8 | (53.3) | 14 | (42.4) | ||
1500≤ | 26 | (76.5) | 4 | (26.7) | 8 | (24.2) | ||
Gender | M | 19 | (55.9) | 12 | (80.0) | 19 | (57.6) | 0.25 |
F | 15 | (44.1) | 3 | (20.0) | 14 | (42.4) |
Table 2.
|
Group 1 |
Group 2–1 |
Group 2–2 |
p value* | ||||
---|---|---|---|---|---|---|---|---|
No | (%) | No | (%) | No | (%) | |||
Refractive error† | | 35 | (51.5) | 19 | (59.4) | 49 | (80.3) | 0.002 |
Anisometropia | | 2 | (5.9) | 6 | (40.0) | 14 | (46.7) | 0.001 |
Strabismus | exodeviation | 6 | (17.6) | 2 | (13.3) | 9 | (27.3) | 0.80 |
| esodeviation | 5 | (14.7) | 4 | (26.7) | 4 | (12.1) | |
Table 3.
|
Group 1 |
Group 2–1 |
Group 2–2 |
p value* | |||
---|---|---|---|---|---|---|---|
No | (%) | No | (%) | No | (%) | ||
Myopia | 16 | (23.5) | 11 | (34.4) | 31 | (50.8) | 0.03 |
Emmetropia | 44 | (64.7) | 18 | (56.3) | 24 | (39.3) | 0.02 |
Hyperopia | 5 | (11.4) | 3 | (16.7) | 6 | (25.0) | 0.872 |
Astigmatism | 22 | (32.4) | 14 | (43.8) | 35 | (57.4) | 0.02 |
Table 4.
|
Group 1 |
Group 2–1 |
Group 2–2 |
p value |
---|---|---|---|---|
Mean ± SD* (D†) | Mean ± SD (D) | Mean ± SD (D) | ||
Myopia | −1.39 ± 1.74 | −1.78 ± 1.74 | −2.73 ± 1.86 | 0.04‡ |
Emmetropia | +0.59 ± 0.57 | +0.87 ± 0.74 | +0.75 ± 0.62 | 0.25‡ |
Hyperopia | +4.05 ± 0.87 | +3.33 ± 0.29 | +6.17 ± 1.03 | 0.01§ |
Astigmatism | 1.93 ± 0.78 | 1.61 ± 0.81 | 2.17 ± 0.88 | 0.10‡ |
Table 5.
| Group 1 | Group 2–1 | Group 2–2 | p value |
---|---|---|---|---|
BCVA (logMAR) | 0.14 ± 0.08 | 0.16 ± 0.07 | 0.27 ± 0.18 | < 0.001* |
Amblyopia No (%) | 3 (15) | 1 (14.3) | 5 (20.8) | 0.85† |